RCKT•benzinga•
Canaccord Genuity Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $36
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 3, 2025 by benzinga